SCHEMBL26338377

SCHEMBL26338377

c1ccc(-c2ccccc2N(c2cccc(-c3ccc4c(c3)c(-c3ccccc3)c(-c3ccccc3)c3ccccc34)c2)c2ccccc2-c2ccccc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ENPP1 P22413 1/20 0.33
▸ HSD17B1 P14061 2/20 0.32
▸ HSD17B2 P37059 2/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2B6 P20813 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ THRA P10827 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ IMPDH2 P12268 1/20 0.31
▸ CRHR1 P34998 1/20 0.30
▸ CA12 O43570 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ CA9 Q16790 1/20 0.30
▸ GPR84 Q9NQS5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26339124 0.97 IMPDH2 (0.32) ENPP1HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL26338249 0.96 IMPDH2 (0.33) ENPP1HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL26338293 0.95 HSD17B1 (0.32) ENPP1HSD17B1HSD17B2THRBIMPDH2
SCHEMBL26339131 0.94 HSD17B1 (0.32) ENPP1HSD17B1HSD17B2THRBIMPDH2
SCHEMBL26338265 0.93 ENPP1 (0.32) ENPP1HSD17B1HSD17B2
SCHEMBL26338309 0.93 IMPDH2 (0.32) ENPP1HSD17B1HSD17B2IMPDH2CRHR1
SCHEMBL26340674 0.93 IMPDH2 (0.32) ENPP1HSD17B1HSD17B2IMPDH2CRHR1
SCHEMBL26338279 0.93 IMPDH2 (0.32) ENPP1HSD17B1HSD17B2IMPDH2CRHR1
SCHEMBL26339137 0.93 ESR1 (0.31) ENPP1HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL26338381 0.92 ENPP1 (0.31) ENPP1CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 ENPP1 546/4885HSD17B1 2697/4885HSD17B2 2994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback